Asset Details
Do you wish to reserve the book?
The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients
Do you wish to request the book?
The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients
2024
Overview
In critical illness the regulation of inflammation and oxidative stress can improve patient outcomes, and thus omega-3 polyunsaturated fatty acids (PUFAs) have been used as part of parenteral nutrition (PN) owing to their potential anti-inflammatory effects. The international lipids in PN Summit, encompassed discussions and the production of consensus guidelines concerning PN intravenous lipid emulsion (ILE) use in critical care. The Lipid Summit participants agreed that the inclusion of fish oil in ILEs is associated with meaningful clinical benefits without signals of harm, based on a strong biological rationale and current clinical evidence. Decisions concerning ILE choice should be made based on current evidence, thus addressing clinical requirements for guidance, particularly as further definitive evidence seems unlikely to occur. In addition, a future of individualized ICU care is envisioned, yielding better clinical outcomes. This approach will require the greater use of intelligent study designs incorporating the use of biomarkers of omega-3 derivatives, inflammatory-resolving processes, and/or muscle protein breakdown.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Fat Emulsions, Intravenous - administration & dosage
/ Fat Emulsions, Intravenous - therapeutic use
/ Fatty Acids, Omega-3 - administration & dosage
/ Fatty Acids, Omega-3 - therapeutic use
/ Fish Oils - administration & dosage
/ Humans
/ Lipids
/ Medicine
/ Parenteral Nutrition - methods
/ Parenteral Nutrition - standards
/ Patients
/ Proteins
/ Soybeans
